VITASPRING BIOMEDICAL CO., LTD. (VSBC) Net margin 2018–2022
VITASPRING BIOMEDICAL CO., LTD. (VSBC) net profit margin by fiscal year — reported net income divided by reported revenue.
16.2%FY2022 · since FY2018: -39.3% → 16.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 16.2% | -155.2 pp |
| FY2021 | 171.4% | +125.7 pp |
| FY2020 | 45.7% | +176.1 pp |
| FY2019 | -130.4% | -91.1 pp |
| FY2018 | -39.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice